Annovis Bio
-
Malvern-Based Annovis Bio Reports Positive Clinical Trial Results for Parkinson’s Disease Drug
Malvern-based Annovis Bio recently reported positive clinical trial results for buntanetap, the biopharmaceutical company’s lead new drug candidate in Parkinson’s disease patients, writes John George…
-
Malvern-Based Annovis Bio to Focus Future Development of Its Experimental Drug on Early Alzheimer’s Patients
Malvern-based Annovis Bio plans to focus on patients who have the early form of Alzheimer’s disease in the future development of its experimental treatment for…
-
Berwyn-Based Annovis Bio Postpones Release of Data for Its Experimental Parkinson’s Treatment
Berwyn-based Annovis Bio is delaying the release of the late-stage study results of its experimental Parkinson’s disease treatment, writes John George for the Philadelphia Business…
-
Positive News About Berwyn-based Annovis Bio’s Experimental Alzheimer’s Therapy Sends Stock Soaring
Positive news about Berwyn-based Annovis Bio’s experimental Alzheimer’s disease therapy bumped the company’s stock up by 16 percent Monday during mid-afternoon trading, writes John George…
-
Berwyn-Based Annovis Bio Creates New Drug Form to Treat Alzheimer’s, Parkinson’s
A Berwyn-based biopharmaceutical company is filing for a patent for its new drug candidate that could potentially treat neurodegenerative diseases. Annovis Bio filed for a…
-
Berwyn Biotech Company Raises Millions to Advance Parkinson’s, Alzheimer’s Treatment
Annovis Bio, a Berwyn-based biotech company, has managed to raise $8.7 million to advance its experimental treatment for Parkinson’s and Alzheimer’s diseases, writes John George…
-
Neither the Pandemic Nor Labor Shortages Could Mute Phila.’s 2021 Venture Capital Boom
Despite the disruptions caused by the coronavirus pandemic and labor shortages, Philadelphia experienced a venture capital boom in 2021, write Taylor Allen and Mike D’Onofrio…
-
Berwyn Biotech Firm with No Products Goes Public Amid Bull Market for Gene-and-Cell-Therapy Stocks
Berwyn-based Annovis Bio is the latest in the line of Philadelphia-area biotech developers to sell shares to the public before having any sales or products,…
-
Berwyn-Based Pharmaceutical Company Going Public
Annovis Bio, the pharmaceutical company in Berwyn working on potential treatments for neurological disorders such as Alzheimer’s and Parkinson’s diseases, has filed for an IPO,…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
